EAACI Congress 2025

Back

13 - 16 June 2025 Glasgow, United Kingdom

SAT3-1 - GSK – Breathing as one: The expanded role of IL-5 inhibition in CRSwNP & Asthma

Sunday 15 Jun, 12:45 PM - 13:45 PM Glasgow, United Kingdom

Forth Sponsored Sessions

Uncover the disease burden and experiences in managing chronic rhinosinusitis with nasal polyps (CRSwNP) through the patient's voice
Strive for ambitious treatment goals with emerging IL-5 science in CRSwNP and Severe Asthma (SA)
Highlight the power of unified airway care in optimising CRSwNP and SA treatment outcomes

12:45

Welcome and Introductions

12:50

Living with CRSwNP: Navigating challenges in the care pathway

13:05

Transforming unified airway care with emerging science

13:20

Breathing as one: Integrating upper and lower airways